Cargando…
Strategically targeting MYC in cancer
MYC is a major driver of cancer cell growth and mediates a transcriptional program spanning cell growth, the cell cycle, metabolism, and cell survival. Many efforts have been made to deliberately target MYC for cancer therapy. A variety of compounds have been generated to inhibit MYC function or sta...
Autores principales: | Posternak, Valeriya, Cole, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813636/ https://www.ncbi.nlm.nih.gov/pubmed/27081479 http://dx.doi.org/10.12688/f1000research.7879.1 |
Ejemplares similares
-
Targeting MYC Dependence by Metabolic Inhibitors in Cancer
por: Sabnis, Himalee S., et al.
Publicado: (2017) -
The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy
por: Savino, Mauro, et al.
Publicado: (2011) -
Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017) -
Rationale for MYC imaging and targeting in pancreatic cancer
por: Schneider, Günter, et al.
Publicado: (2021) -
Target c-Myc to treat pancreatic cancer
por: Ala, Moein
Publicado: (2022)